SCHEMBL5852142

SCHEMBL5852142

O=P(OCl)(OC1CCCC1)OC1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
NPSR1 Q6W5P4 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330611 0.98 ACHE (0.47) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL5850412 0.90 INPP5A (0.32) ACHE
SCHEMBL19348575 0.87 ACHE (0.38) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL1009596 0.85 ACHE (0.41) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL10570508 0.85 ACHE (0.46) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL156375 0.84 ACHE (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL145689 0.81 ACHE (0.54) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL159389 0.81 ACHE (0.54) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL31427640 0.81 ACHE (0.54) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL158755 0.81 ACHE (0.54) ACHENPSR1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117487327-A Flame-retardant low-dielectric-strength PBT composite material and preparation method thereof 江苏康辉新材料科技有限公司 2024-02-02 CN disclosed
CN-117487328-A Furanyl polyester composition with high barrier property and high crystallization property and preparation method thereof 江苏康辉新材料科技有限公司 2024-02-02 CN disclosed
CN-117362941-A Refrigerant-resistant flame-retardant high-glass fiber reinforced PBT composite material with high crystallization temperature and preparation method thereof 江苏康辉新材料科技有限公司 2024-01-09 CN disclosed
CN-117327377-A Bio-based phosphonamide flame retardant nucleating agent reinforced PBT (polybutylene terephthalate) composition and preparation method thereof 江苏康辉新材料科技有限公司 2024-01-02 CN disclosed
EP-3222624-B1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO LTD (JP) 2019-11-06 EP disclosed
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CENTRAL GLASS CO., LTD. (JP) 2019-05-14 US disclosed
EP-3222624-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME Central Glass Co., Ltd. (JP) 2017-09-27 EP disclosed
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CENTRAL GLASS CO., LTD. (JP) 2017-09-21 US disclosed
US-7153901-B2 Low viscosity flame retardants are the reaction product of a mixed ester of tetrabromophthalic acid with diethylene glycol and propylene glycol with an acid anhydride, organic phosphate, or organic chlorophosphate; minimizing visible scorching of the flexible polyurethane foam during its production ALBEMARLE CORPORATION (US) 2006-12-26 US disclosed
EP-1685176-A2 FLAME RETARDANT, ADDITIVE COMPOSITIONS, AND FLAME RETARDANT POLYURETHANES ALBEMARLE CORPORATION (US) 2006-08-02 EP disclosed
WO-2005052018-A2 FLAME RETARDANT, ADDITIVE COMPOSITIONS, AND FLAME RETARDANT POLYURETHANES ALBEMARLE CORPORATION (US) 2005-06-09 WO disclosed
US-20050113495-A1 Flame retardant, additive compositions, and flame retardant polyurethanes ALBEMARLE CORPORATION 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267528-A1 IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME CA2, CA6, CHRM1 ACHE 559/4885NPSR1 2339/4885MEN1 233/4885
US-10287165-B2 Imidic acid compound having divalent anion and process for producing the same CA2, CA6, CHRM1 ACHE 559/4885NPSR1 2339/4885MEN1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.